RxDoctor Payments Data

Shannon Engel, DPM

Podiatrist · St. Joseph, MONPI 1649220302

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Stryker at 46.7% of the total. Reporting peaked in 2019 at $705 and has fallen 53.2% since, to $330 in 2025.

$2,483in general payments, 2019–2025

Across 71 payments — averaging $34.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1K
  • Mimedx Group, Inc.$437
  • Tenex Health Inc.$292
  • Amgen$158
  • Smith+Nephew$141
  • Melinta Therapeutics, LLC$70
  • plus $224 from 9 others

What the payments were for

  • Food & beverage$2,483100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker(2 entities)11$1,159
Mimedx Group, Inc.16$437
Tenex Health Inc.2$292
Amgen20$158
Smith+Nephew2$141
Melinta Therapeutics, LLC5$70
Zyla Life Sciences, Inc.5$69
Integra Lifesciences Corporation3$55
Vertex1$21
KCI USA, Inc.1$18
Paratek Pharmaceuticals, Inc.1$17
Organogenesis Inc.1$15
Zimmer Biomet1$14
Assertio Therapeutics, Inc.1$11
Prugen, Inc. Pharmaceuticals1$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,483 in reported general payments places this provider in the 60th percentile of 105 podiatrist providers in Missouri.

See all podiatrist providers in Missouri

Medicare billing

Part B allowed, 2024
$158,907
Medicare patients
769
Services billed
2,510

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin177$2,169
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen140$1,141
Ammonium Lactate41$998
Diclofenac Sodium47$978
Ciclopirox21$807
Cephalexin130$759
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim87$648
Celecoxib24$575
Terbinafine Hcl45$499
Doxycycline Hyclate37$482
Pregabalin36$456
CiclopiroxCiclopirox Olamine39$414
Tramadol Hcl99$308
Prednisone66$276
Mupirocin16$123

Paid to pharmacies, not to this prescriber.

Other podiatrist in St. Joseph

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →